Info
Fotografie: Matouš Vokatý (2. LF)
‘Gene therapy for Duchenne must meet high evidence standards before broad adoption’
‘Gene therapy for Duchenne must meet high evidence standards before broad adoption’
Hannah Jolly, Annemieke Aartsma-Rus, Enrico Bertini, Liesbeth De Waele, Jana Haberlová, Andrea Klein, Erik Niks, Laurent Servais | The Lancet | May 2025 | IF = 88 | doi
Gene therapy approval for Duchenne muscular dystrophy: a European perspective – full text (The Lancet)
